Monoclonal anti-T cell (T12) antibody treatment of graft-versus-host disease in severe combined immunodeficiency: targeting of antibody and activation of complement on CD8+ cytotoxic T cell surfaces.

Source:http://linkedlifedata.com/resource/pubmed/id/1902852

Download in:

View as

General Info

PMID
1902852